Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glycosaminoglycans | 4 | 2023 | 624 | 1.230 |
Why?
|
| Sepsis | 5 | 2023 | 2593 | 0.760 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2021 | 118 | 0.750 |
Why?
|
| Glycocalyx | 5 | 2023 | 89 | 0.740 |
Why?
|
| Heparitin Sulfate | 8 | 2023 | 225 | 0.710 |
Why?
|
| Pulmonary Artery | 3 | 2019 | 1911 | 0.690 |
Why?
|
| Sulfotransferases | 1 | 2019 | 151 | 0.660 |
Why?
|
| Aneurysm | 1 | 2019 | 339 | 0.550 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 3 | 2023 | 687 | 0.420 |
Why?
|
| Lung | 5 | 2023 | 9858 | 0.380 |
Why?
|
| Pneumonia, Bacterial | 2 | 2023 | 316 | 0.360 |
Why?
|
| Chondroitin Sulfates | 3 | 2023 | 187 | 0.330 |
Why?
|
| Hemodynamics | 2 | 2016 | 4197 | 0.320 |
Why?
|
| Pneumonia | 1 | 2019 | 2133 | 0.300 |
Why?
|
| Endothelial Cells | 1 | 2019 | 3482 | 0.280 |
Why?
|
| Lung Injury | 2 | 2020 | 432 | 0.240 |
Why?
|
| Decorin | 1 | 2023 | 40 | 0.240 |
Why?
|
| Disease Models, Animal | 3 | 2023 | 18027 | 0.240 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10477 | 0.230 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2023 | 43 | 0.220 |
Why?
|
| Proteoglycans | 2 | 2023 | 837 | 0.210 |
Why?
|
| Silver Staining | 1 | 2021 | 64 | 0.200 |
Why?
|
| Oligosaccharides | 2 | 2023 | 415 | 0.200 |
Why?
|
| Pulmonary Atelectasis | 1 | 2022 | 145 | 0.190 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2023 | 850 | 0.170 |
Why?
|
| Acute Lung Injury | 1 | 2023 | 380 | 0.170 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2021 | 1800 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2019 | 8300 | 0.150 |
Why?
|
| Pulmonary Alveoli | 1 | 2020 | 674 | 0.150 |
Why?
|
| Hippocampus | 2 | 2019 | 3672 | 0.140 |
Why?
|
| Animals | 15 | 2024 | 168660 | 0.130 |
Why?
|
| Mice | 11 | 2024 | 81154 | 0.130 |
Why?
|
| Staphylococcal Infections | 1 | 2024 | 1400 | 0.120 |
Why?
|
| Lipopolysaccharides | 2 | 2019 | 2217 | 0.120 |
Why?
|
| Hypertension, Pulmonary | 2 | 2016 | 1534 | 0.120 |
Why?
|
| Rats | 3 | 2019 | 24250 | 0.110 |
Why?
|
| Heparin | 1 | 2019 | 1637 | 0.100 |
Why?
|
| Memory Disorders | 1 | 2019 | 1186 | 0.100 |
Why?
|
| Influenza, Human | 1 | 2022 | 1480 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 21824 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2024 | 7880 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2018 | 4459 | 0.070 |
Why?
|
| Staphylococcus aureus | 2 | 2024 | 1453 | 0.060 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2019 | 604 | 0.060 |
Why?
|
| Cathelicidins | 1 | 2023 | 80 | 0.060 |
Why?
|
| Trypsin | 1 | 2024 | 511 | 0.060 |
Why?
|
| Disaccharides | 1 | 2023 | 171 | 0.060 |
Why?
|
| Syndecan-1 | 1 | 2023 | 165 | 0.050 |
Why?
|
| Cytotoxins | 1 | 2022 | 153 | 0.050 |
Why?
|
| Ion Exchange | 1 | 2021 | 16 | 0.050 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2023 | 362 | 0.050 |
Why?
|
| Desiccation | 1 | 2021 | 71 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2024 | 633 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2016 | 9139 | 0.050 |
Why?
|
| Male | 7 | 2022 | 349776 | 0.050 |
Why?
|
| Solutions | 1 | 2021 | 426 | 0.050 |
Why?
|
| Superoxide Dismutase | 1 | 2023 | 595 | 0.050 |
Why?
|
| Biofilms | 1 | 2024 | 615 | 0.040 |
Why?
|
| Bleomycin | 1 | 2020 | 512 | 0.040 |
Why?
|
| Syndecans | 1 | 2018 | 79 | 0.040 |
Why?
|
| Virulence | 1 | 2022 | 1328 | 0.040 |
Why?
|
| Glucuronidase | 1 | 2020 | 207 | 0.040 |
Why?
|
| Matrix Metalloproteinases | 1 | 2020 | 391 | 0.040 |
Why?
|
| Long-Term Potentiation | 1 | 2019 | 293 | 0.040 |
Why?
|
| Humans | 9 | 2024 | 743811 | 0.040 |
Why?
|
| Respiratory Mechanics | 1 | 2020 | 686 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2020 | 1615 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2018 | 798 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2022 | 1358 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2022 | 1743 | 0.030 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2013 | 57 | 0.030 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2022 | 808 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2020 | 1678 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2020 | 4221 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2022 | 2568 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2024 | 3850 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2013 | 974 | 0.020 |
Why?
|
| Sex Factors | 1 | 2022 | 10394 | 0.020 |
Why?
|
| Pyrroles | 1 | 2013 | 1147 | 0.020 |
Why?
|
| Female | 3 | 2022 | 380020 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2022 | 15067 | 0.020 |
Why?
|
| Cell Line | 1 | 2020 | 15993 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 7172 | 0.020 |
Why?
|
| Indoles | 1 | 2013 | 1841 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 19894 | 0.010 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2013 | 2037 | 0.010 |
Why?
|
| Inflammation | 1 | 2023 | 10629 | 0.010 |
Why?
|
| Cognition | 1 | 2019 | 6759 | 0.010 |
Why?
|
| Prognosis | 1 | 2022 | 29052 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2023 | 53250 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2020 | 23398 | 0.010 |
Why?
|
| Child | 1 | 2023 | 77637 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 77410 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 72252 | 0.010 |
Why?
|
Concepts
(94)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(3)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_